focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.50
Bid: 23.20
Ask: 26.00
Change: 0.00 (0.00%)
Spread: 2.80 (12.069%)
Open: 24.50
High: 0.00
Low: 0.00
Prev. Close: 24.50
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: SkinBio launches food supplement on Amazon

Thu, 30th Nov 2023 14:25

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Iofina PLC - Colorado, US-based manufacturing company that specialises in the production of iodine and the manufacture of speciality chemical derivatives - Reminds investors that the ramp-up of IO9, its iodine plant in Western Oklahoma, took longer than expected. Says that recent upgrades have improved the flow of brine water to the plant, adding that it has been able to steadily increase crystalline iodine production following the completion of this work. Confirms that the plant is now operating within its expected output range. Expects second-half production at the bottom, or very marginally below, the bottom end of the forecast range of 325 to 350 metric tonnes.

----------

SkinBioTherapeutics PLC - Newcastle, England-based life science company focused on skin health - Says that its AxisBiotix-Ps food supplement will launch on Amazon.co.uk from December 6. AxisBiotix-Ps is designed to help alleviate sensitive skin conditions like psoriasis. SkinBio Therapeutics says the sale of the product on Amazon is a key part of its commercialisation strategy, and that it aims to extend product availability through other Amazon country sites. Says management is already proactively seeking to expand online sales of AxisBiotix-Ps into France, Italy, and Spain, where the product has regulatory clearance.

----------

Oncimmune Holdings PLC - Nottingham, England-based immunodiagnostics developer - Notes strategic progress towards end of first quarter, including contracts signed for four new projects, with additional contracts approved by customers and due to be signed in the second quarter. Says three of the contracts are with major pharmaceutical companies who were existing customers, while the fourth is with a new customer focused on "high throughput drug discovery". Chief Executive Officer Martin Gouldstone says: "I am encouraged to see the commercial traction already being made on delivering our strategy, including our ability to expand the application of our ImmunoINSIGHTS platform into drug discovery as well as clinical trials. I have recently spent time discussing our strategy with some of our key stakeholders and have been pleased to see how well it has been received, also allowing us to recruit top talent to further accelerate our ability to deliver on it."

----------

Baron Oil PLC - London-based oil & gas exploration and appraisal company - Celebrates as its wholly-owned owned subsidiary, SundaGas Banda Unipessoal Lda, gets project classification from Autoridade Nacional do Petroleo for the Chuditch field. Sundagas is the operator of the TL-SO-19-16 production sharing contract, offshore Timor-Leste, while ANP is the Timor-Leste government regulator for oil and gas. The next step is the submission of a term of reference, including initial public consultations. Baron Oil adds that, regarding drilling, a Timorese drilling engineer has been recruited to join the SundaGas well operations team, and expressions of interest are being sought from in-country suppliers to provide services from the Timorese private sector. It also continues to evaluate all potential options for gas export from the Chuditch field in order to be able to fast track the concept selection processes.

----------

Arkle Resources PLC - Exploration company, with principal assets in Irish gold and zinc exploration licences - Says a drilling programme at Inishowen in County Donegal is due to begin this week. The drilling, which is a follow-up to work at the Meeneragh target, will test the main gold bearing outcrop. Four holes are planned in this phase from two drill pads drilling at minus 45 and minus 70 degrees. The focus of the programme will be on the main vein target discovered earlier. Chair John Teeling says: "It is good to get back on the ground again at Inishowen. This new round of drilling will test to see if we can trace the main vein along strike and at depth. We found high grade gold in the area and we now aim to expand this."

----------

By Holly Beveridge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 Sep 2020 13:49

Oncimmune announces autoantibody profiling collaboration

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has signed an autoantibody profiling collaboration with an unnamed "leading global biopharmaceutical company", it announced on Wednesday, which it said had "extensive experience" in developing novel immune checkpoint inhibitors (CPIs).

Read more
27 Jul 2020 18:11

IN BRIEF: Oncimmune Notes Expanded Profiling Contract With Roche

IN BRIEF: Oncimmune Notes Expanded Profiling Contract With Roche

Read more
27 Jul 2020 09:22

Roche extends scope and value of contract with Oncimmune

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced on Monday that Roche has exercised its option to increase the scope and value of the cornerstone contract, initially announced on 28 May.

Read more
2 Jul 2020 06:54

IN BRIEF: Oncimmune's EarlyCDT Gets Marketing Authorisation In Brazil

IN BRIEF: Oncimmune's EarlyCDT Gets Marketing Authorisation In Brazil

Read more
5 Jun 2020 14:10

UK DIRECTOR DEALINGS SUMMARY: Avast Non-Exec Sells 500,000 Shares

UK DIRECTOR DEALINGS SUMMARY: Avast Non-Exec Sells 500,000 Shares

Read more
4 Jun 2020 13:19

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

Read more
4 Jun 2020 10:50

Oncimmune expects to report further strong top-line growth

(Sharecast News) - Immunodiagnostics group Oncimmune Holdings said on Thursday that it expects to report further strong top-line growth in its current trading year.

Read more
28 May 2020 15:32

Oncimmune Inks Further Roche Contract Focused On Immunotherapy Trials

Oncimmune Inks Further Roche Contract Focused On Immunotherapy Trials

Read more
12 May 2020 16:42

Oncimmune Signs Drug Development Deal With US Biopharmaceutical Firm

Oncimmune Signs Drug Development Deal With US Biopharmaceutical Firm

Read more
12 May 2020 15:32

Oncimmune signs collaboration deal with US biopharma company

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has signed an antigen-targeting collaboration, it announced on Tuesday, to support drug development with a "leading", unnamed United States biopharmaceutical company, which is developing novel therapies based on the human immune response.

Read more
6 May 2020 14:57

UK DIRECTOR DEALINGS SUMMARY: Burford Capital Chiefs Spend GBP425,000

UK DIRECTOR DEALINGS SUMMARY: Burford Capital Chiefs Spend GBP425,000

Read more
5 May 2020 11:50

UK EXECUTIVE CHANGE SUMMARY: Sigma Capital Taps Former Countryside CEO

UK EXECUTIVE CHANGE SUMMARY: Sigma Capital Taps Former Countryside CEO

Read more
18 Mar 2020 18:09

DIRECTOR DEALINGS SUMMARY: Wizz Air Chair Buys GBP700,000 In Shares

DIRECTOR DEALINGS SUMMARY: Wizz Air Chair Buys GBP700,000 In Shares

Read more
18 Mar 2020 07:30

UK Advisory Body Gives Oncimmune's Lung Cancer Test Positive Review

UK Advisory Body Gives Oncimmune's Lung Cancer Test Positive Review

Read more
4 Mar 2020 12:57

Oncimmune EarlyCDT Lung Test Launched In US By Commercial Partner

Oncimmune EarlyCDT Lung Test Launched In US By Commercial Partner

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.